CRVS
Corvus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.39
−1.77%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.35x
Liquidity & coverage
- Current ratio
- 16.16x
- Quick ratio
- 16.16x
- Cash ratio
- 15.74x
- Interest coverage
- -31.93x
- EBITDA / interest
- -28.86x
- Working capital
- $207.3M
Cash & dividend
- FCF / debt
- -62.13x
- Cash flow / debt
- -61.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026